Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine

22 Jul 2023

Abstract excerpt

Induced pluripotent stem cells (iPSC) have huge potential as cell therapy for various diseases, given their potential for unlimited self-renewal and capability to differentiate into a wide range of cell types. Although autologous iPSCs represents the ideal source for patient-tailored regenerative medicine, the high costs of the extensive and time-consuming production process and the impracticability for treating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37511568
DOI: 10.3390/ijms241411810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative MedicinePMID 37511568Read ↗

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationSemantic proximity Read ↗

Generation of universal and hypoimmunogenic human pluripotent stem cellsSemantic proximity Read ↗

Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunitySemantic proximity Read ↗

Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editingSemantic proximity Read ↗

Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockoutSemantic proximity Read ↗

CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)Semantic proximity Read ↗

Generation of hypoimmunogenic universal iPSCs through HLA-type gene knockoutSemantic proximity Read ↗

Hypoimmunogenic Human Pluripotent Stem Cells are Valid Cell Sources for Cell Therapeutics with Normal Self-Renewal and Multi-Lineage Differentiation CapacitySemantic proximity Read ↗

iPSC modification strategies to induce immune toleranceSemantic proximity Read ↗

Generation of hypoimmunogenic human pluripotent stem cellsSemantic proximity Read ↗

B2M gene knockout in HEK293T cells by non-viral delivery of CRISPR-Cas9 for the induction of universal cellSemantic proximity Read ↗

CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.